Trial Profile
A single center, open-label study evaluating pharmacokinetic sof Vosaroxin in patients with advanced solid tumours.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Feb 2017
Price :
$35
*
At a glance
- Drugs Vosaroxin (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 06 Feb 2017 New trial record
- 31 Jan 2017 Results published in the Investigational New Drugs